Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / Fund iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CUS1(GBX) LSE
ETF Ticker CUSS(USD) LSE
ETF Ticker SXRG(EUR) F
ETF Ticker CSUSS.MI(EUR) CXE
ETF Ticker CSUSSz(USD) CXE
ETF Ticker CUSS.LS(USD) CXE
ETF Ticker CSUSS(EUR) ETF Plus
ETF Ticker CUS1.L(GBP) LSE
ETF Ticker CUSS.L(GBP) LSE

Holdings detail for MRUS

Stock Name	Merus BV
Ticker	MRUS(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	NL0011606264

Show aggregate MRUS holdings

News associated with MRUS

Merus N.V. (NASDAQ:MRUS) Receives Average Recommendation of “Buy” from Analysts: Merus N.V. (NASDAQ:MRUS – Get Free Report) has received an average recommendation of “Buy” from the twelve research firms that are covering the firm, Marketbeat.com reports. Eleven analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price objective among brokerages that […] - 2025-09-04 03:06:58
Merus (NASDAQ:MRUS) Coverage Initiated at Alliance Global Partners: Research analysts at Alliance Global Partners started coverage on shares of Merus (NASDAQ:MRUS – Get Free Report) in a research note issued on Monday, MarketBeat reports. The firm set a “buy” rating and a $90.00 price target on the biotechnology company’s stock. Alliance Global Partners’ target price suggests a potential upside of 34.61% from the […] - 2025-08-27 02:30:45
Leerink Partnrs Estimates Merus’ Q3 Earnings (NASDAQ:MRUS): Merus N.V. (NASDAQ:MRUS – Free Report) – Analysts at Leerink Partnrs dropped their Q3 2025 EPS estimates for Merus in a report issued on Wednesday, August 6th. Leerink Partnrs analyst A. Berens now forecasts that the biotechnology company will post earnings per share of ($1.50) for the quarter, down from their prior estimate of ($1.32). […] - 2025-08-12 02:46:48
Merus (NASDAQ:MRUS) Downgraded to Sell Rating by Wall Street Zen: Merus (NASDAQ:MRUS – Get Free Report) was downgraded by stock analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued on Sunday. A number of other research analysts have also issued reports on the company. Needham & Company LLC reiterated a “buy” rating and set a $75.00 […] - 2025-07-22 02:07:06
Wall Street Zen Upgrades Merus (NASDAQ:MRUS) to “Hold”: Merus (NASDAQ:MRUS – Get Free Report) was upgraded by research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a report issued on Saturday. A number of other brokerages have also issued reports on MRUS. William Blair reaffirmed an “outperform” rating on shares of Merus in a research report on […] - 2025-07-14 03:40:50
Insider Selling: Merus N.V. (NASDAQ:MRUS) COO Sells $1,793,840.00 in Stock: Merus N.V. (NASDAQ:MRUS – Get Free Report) COO Peter B. Silverman sold 34,000 shares of the firm’s stock in a transaction dated Friday, June 20th. The shares were sold at an average price of $52.76, for a total value of $1,793,840.00. The sale was disclosed in a legal filing with the SEC, which is accessible […] - 2025-06-27 05:10:52
Merus N.V. (NASDAQ:MRUS) Receives $84.64 Average Price Target from Brokerages: Merus N.V. (NASDAQ:MRUS – Get Free Report) has been assigned a consensus rating of “Buy” from the fourteen analysts that are currently covering the firm, MarketBeat reports. Twelve equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average 1-year target price […] - 2025-06-24 02:36:57
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 14,544 Shares of Merus (NASDAQ:MRUS): UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in Merus (NASDAQ:MRUS – Free Report) by 17.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 98,744 shares of the biotechnology company’s stock after purchasing an additional 14,544 shares […] - 2025-06-05 05:13:00
Merus Prices 5.26 Mln Shares At $57/Shr In Public Offering; To Raise Around $300 Mln: (RTTNews) - Merus N.V. (MRUS), a Dutch oncology company developing multispecific antibodies and antibody drug conjugates, Wednesday announced the pricing of an underwritten public offering of around 5.26 million shares, at a price of $57.00 per share. The gross proceeds from the - 2025-06-04 01:56:43
Merus N.V. Announces Pricing of $300 Million Public Offering of Common Shares: Merus N.V. announced a $300 million public offering of 5.26 million common shares to fund clinical development and research. - 2025-06-04 01:20:22
Analysts Anticipate 25% Gains Ahead For The Holdings of FHLC: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-29 08:03:59
Merus (NASDAQ:MRUS) Earns Buy Rating from Needham & Company LLC: Merus (NASDAQ:MRUS – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at Needham & Company LLC in a research report issued to clients and investors on Monday,Benzinga reports. They currently have a $75.00 target price on the biotechnology company’s stock. Needham & Company LLC’s price target points to a potential upside […] - 2025-05-21 03:03:18
Merus (NASDAQ:MRUS) Holdings Decreased by The Manufacturers Life Insurance Company: The Manufacturers Life Insurance Company reduced its stake in shares of Merus (NASDAQ:MRUS – Free Report) by 17.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 42,085 shares of the biotechnology company’s stock after selling 9,204 shares during the quarter. […] - 2025-05-12 05:36:50
Tudor Investment Corp ET AL Purchases Shares of 5,075 Merus (NASDAQ:MRUS): Tudor Investment Corp ET AL bought a new stake in Merus (NASDAQ:MRUS – Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 5,075 shares of the biotechnology company’s stock, valued at approximately $213,000. A number of other institutional investors and hedge […] - 2025-05-11 05:44:52
Tower Research Capital LLC TRC Decreases Stock Holdings in Merus (NASDAQ:MRUS): Tower Research Capital LLC TRC decreased its stake in shares of Merus (NASDAQ:MRUS – Free Report) by 77.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,668 shares of the biotechnology company’s stock after selling 9,221 shares during the […] - 2025-05-09 05:21:09
Merus (NASDAQ:MRUS) Short Interest Update: Merus (NASDAQ:MRUS – Get Free Report) was the target of a significant decrease in short interest in the month of April. As of April 15th, there was short interest totalling 6,270,000 shares, a decrease of 15.5% from the March 31st total of 7,420,000 shares. Currently, 9.6% of the company’s shares are sold short. Based on […] - 2025-05-05 04:58:56
Merus (NASDAQ:MRUS) Earns “Outperform” Rating from William Blair: William Blair reaffirmed their outperform rating on shares of Merus (NASDAQ:MRUS – Free Report) in a report issued on Monday morning,RTT News reports. Several other analysts have also commented on the stock. Guggenheim reissued a “buy” rating and set a $109.00 target price on shares of Merus in a research note on Friday, March 28th. […] - 2025-04-29 04:54:48
Invesco Ltd. Grows Stock Position in Merus (NASDAQ:MRUS): Invesco Ltd. lifted its holdings in Merus (NASDAQ:MRUS – Free Report) by 2.2% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 786,365 shares of the biotechnology company’s stock after purchasing an additional 16,712 shares during the period. Invesco Ltd. owned about 1.15% of Merus […] - 2025-04-18 05:18:50
HighTower Advisors LLC Has $337,000 Stock Position in Merus (NASDAQ:MRUS): HighTower Advisors LLC lifted its position in Merus (NASDAQ:MRUS – Free Report) by 10.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,020 shares of the biotechnology company’s stock after buying an additional 789 shares during the period. HighTower […] - 2025-04-02 04:14:47
Guggenheim Reiterates Buy Rating for Merus (NASDAQ:MRUS): Merus (NASDAQ:MRUS – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at Guggenheim in a report issued on Tuesday,Benzinga reports. They presently have a $109.00 target price on the biotechnology company’s stock. Guggenheim’s price objective indicates a potential upside of 131.91% from the company’s previous close. Other research analysts also recently […] - 2025-03-20 04:55:00
Bank of America Has Lowered Expectations for Merus (NASDAQ:MRUS) Stock Price: Merus (NASDAQ:MRUS – Get Free Report) had its target price lowered by analysts at Bank of America from $73.00 to $70.00 in a note issued to investors on Monday,Benzinga reports. The firm currently has a “buy” rating on the biotechnology company’s stock. Bank of America‘s price objective indicates a potential upside of 47.12% from the […] - 2025-03-12 04:00:48
HC Wainwright Reaffirms “Buy” Rating for Merus (NASDAQ:MRUS): Merus (NASDAQ:MRUS – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at HC Wainwright in a note issued to investors on Monday,Benzinga reports. They currently have a $85.00 price objective on the biotechnology company’s stock. HC Wainwright’s price target would suggest a potential upside of 90.41% from the stock’s previous close. […] - 2025-03-05 04:32:51
William Blair Predicts Merus’ FY2028 Earnings (NASDAQ:MRUS): Merus (NASDAQ:MRUS – Free Report) – William Blair issued their FY2028 EPS estimates for Merus in a report issued on Friday, February 28th. William Blair analyst M. Phipps expects that the biotechnology company will post earnings per share of ($3.58) for the year. William Blair has a “Outperform” rating on the stock. The consensus estimate […] - 2025-03-04 06:28:57
Merus (NASDAQ:MRUS) Given New $83.00 Price Target at Needham & Company LLC: Merus (NASDAQ:MRUS – Free Report) had its price objective lowered by Needham & Company LLC from $85.00 to $83.00 in a research note released on Friday morning,Benzinga reports. The firm currently has a buy rating on the biotechnology company’s stock. A number of other equities analysts have also recently commented on the company. The Goldman […] - 2025-03-03 04:54:51
Merus (NASDAQ:MRUS) Shares Purchased by State of New Jersey Common Pension Fund D: State of New Jersey Common Pension Fund D grew its holdings in shares of Merus (NASDAQ:MRUS – Free Report) by 29.0% during the 4th quarter, HoldingsChannel reports. The firm owned 48,268 shares of the biotechnology company’s stock after buying an additional 10,842 shares during the period. State of New Jersey Common Pension Fund D’s holdings […] - 2025-02-24 06:42:49
Analysts Set Merus (NASDAQ:MRUS) PT at $85.92: Shares of Merus (NASDAQ:MRUS – Get Free Report) have been assigned a consensus recommendation of “Buy” from the sixteen research firms that are covering the stock, MarketBeat reports. Fourteen equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average twelve-month price […] - 2025-02-19 04:46:55
KBC Group NV Has $2.41 Million Stake in Merus (NASDAQ:MRUS): KBC Group NV raised its position in Merus (NASDAQ:MRUS – Free Report) by 4,583.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 57,234 shares of the biotechnology company’s stock after purchasing an additional 56,012 shares during the quarter. KBC Group NV’s holdings in […] - 2025-02-02 07:28:57

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc MRUS holdings

Date	Number of MRUS Shares Held	Base Market Value of MRUS Shares	Local Market Value of MRUS Shares	Change in MRUS Shares Held	Change in MRUS Base Value	Current Price per MRUS Share Held	Previous Price per MRUS Share Held
2025-09-26 (Friday)	26,675	USD 1,837,641	USD 1,837,641
2025-09-25 (Thursday)	26,675	USD 1,816,568	USD 1,816,568	0	USD -4,001	USD 68.1	USD 68.25
2025-09-24 (Wednesday)	26,675	USD 1,820,569	USD 1,820,569
2025-09-17 (Wednesday)	26,503	USD 1,806,842	USD 1,806,842	0	USD 33,791	USD 68.175	USD 66.9
2025-09-16 (Tuesday)	26,503	USD 1,773,051	USD 1,773,051
2025-09-12 (Friday)	26,331	USD 1,832,111	USD 1,832,111
2025-09-11 (Thursday)	26,331	USD 1,837,904	USD 1,837,904	344	USD 91,837	USD 69.8	USD 67.19

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of MRUS by Blackrock for IE00B3VWM098

Show aggregate share trades of MRUS

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-09-11 BUY 344 69.800* 48.07
2025-08-21 SELL -72 66.650* 47.96 Profit of 3,453 on sale
2025-07-31 BUY 216 66.240* 47.75
2025-06-30 SELL -144 52.600* 46.40 Profit of 6,681 on sale
2025-06-25 SELL -72 53.880* 46.25 Profit of 3,330 on sale
2025-06-20 SELL -144 53.105* 46.10 Profit of 6,638 on sale
2025-05-26 BUY 72 55.140* 44.69
2025-05-19 SELL -72 41.360* 44.68 Profit of 3,217 on sale
2025-05-15 SELL -219 40.080* 44.74 Profit of 9,799 on sale
2025-05-12 SELL -73 42.410* 44.84 Profit of 3,273 on sale
2025-05-09 SELL -73 40.900* 44.87 Profit of 3,276 on sale
2025-04-30 SELL -73 45.510* 45.01 Profit of 3,286 on sale
2025-04-24 SELL -146 44.360* 45.03 Profit of 6,574 on sale
2025-04-17 SELL -73 43.055* 45.14 Profit of 3,295 on sale
2025-04-15 SELL -219 43.220* 45.20 Profit of 9,898 on sale
2025-04-14 SELL -219 42.430* 45.23 Profit of 9,905 on sale
2025-04-09 SELL -292 39.560* 45.41 Profit of 13,258 on sale
2025-04-07 SELL -511 37.390* 45.62 Profit of 23,312 on sale
2025-04-04 SELL -730 38.110* 45.71 Profit of 33,368 on sale
2025-03-31 BUY 73 42.090* 45.86
2025-03-19 SELL -146 47.000* 45.79 Profit of 6,685 on sale
2025-03-14 SELL -438 47.100* 45.74 Profit of 20,035 on sale
2025-03-13 SELL -146 47.640* 45.71 Profit of 6,674 on sale
2025-03-12 SELL -2,482 49.160* 45.66 Profit of 113,340 on sale
2025-03-07 SELL -146 46.070* 45.61 Profit of 6,660 on sale
2025-03-06 SELL -219 46.100* 45.61 Profit of 9,988 on sale
2025-03-03 SELL -73 45.470* 45.61 Profit of 3,330 on sale
2025-02-28 SELL -17,477 47.090* 45.59 Profit of 796,745 on sale
2025-02-26 SELL -118 45.530* 45.58 Profit of 5,378 on sale
2025-02-25 SELL -354 44.400* 45.60 Profit of 16,142 on sale
2025-02-18 BUY 590 42.270* 45.58
2025-02-13 BUY 118 40.300* 45.90
2025-02-12 BUY 118 40.260* 46.01
2025-02-11 BUY 354 40.110* 46.14
2025-02-06 BUY 1,062 41.540* 46.47
2025-01-27 BUY 118 40.400* 47.68
2024-12-30 BUY 590 41.890* 48.41
2024-12-06 BUY 472 44.650* 48.87
2024-12-05 BUY 118 43.860* 49.04
2024-12-04 BUY 590 45.485* 49.17
2024-11-29 BUY 590 44.840* 49.49
2024-11-27 BUY 468 44.970* 49.88
2024-11-26 BUY 117 45.870* 50.06
2024-11-21 BUY 585 44.355* 50.85
2024-11-20 BUY 351 42.930* 51.29
2024-11-18 BUY 1,404 44.270* 52.22
2024-11-12 BUY 936 51.630* 52.25
2024-11-08 BUY 585 54.500* 52.09
2024-11-07 BUY 1,755 54.500* 51.91
2024-11-06 BUY 234 53.130* 51.81
2024-10-31 BUY 117 49.930* 52.31
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-09-11	BUY	344	69.800*	48.07
2025-08-21	SELL	-72	66.650*	47.96 Profit of 3,453 on sale
2025-07-31	BUY	216	66.240*	47.75
2025-06-30	SELL	-144	52.600*	46.40 Profit of 6,681 on sale
2025-06-25	SELL	-72	53.880*	46.25 Profit of 3,330 on sale
2025-06-20	SELL	-144	53.105*	46.10 Profit of 6,638 on sale
2025-05-26	BUY	72	55.140*	44.69
2025-05-19	SELL	-72	41.360*	44.68 Profit of 3,217 on sale
2025-05-15	SELL	-219	40.080*	44.74 Profit of 9,799 on sale
2025-05-12	SELL	-73	42.410*	44.84 Profit of 3,273 on sale
2025-05-09	SELL	-73	40.900*	44.87 Profit of 3,276 on sale
2025-04-30	SELL	-73	45.510*	45.01 Profit of 3,286 on sale
2025-04-24	SELL	-146	44.360*	45.03 Profit of 6,574 on sale
2025-04-17	SELL	-73	43.055*	45.14 Profit of 3,295 on sale
2025-04-15	SELL	-219	43.220*	45.20 Profit of 9,898 on sale
2025-04-14	SELL	-219	42.430*	45.23 Profit of 9,905 on sale
2025-04-09	SELL	-292	39.560*	45.41 Profit of 13,258 on sale
2025-04-07	SELL	-511	37.390*	45.62 Profit of 23,312 on sale
2025-04-04	SELL	-730	38.110*	45.71 Profit of 33,368 on sale
2025-03-31	BUY	73	42.090*	45.86
2025-03-19	SELL	-146	47.000*	45.79 Profit of 6,685 on sale
2025-03-14	SELL	-438	47.100*	45.74 Profit of 20,035 on sale
2025-03-13	SELL	-146	47.640*	45.71 Profit of 6,674 on sale
2025-03-12	SELL	-2,482	49.160*	45.66 Profit of 113,340 on sale
2025-03-07	SELL	-146	46.070*	45.61 Profit of 6,660 on sale
2025-03-06	SELL	-219	46.100*	45.61 Profit of 9,988 on sale
2025-03-03	SELL	-73	45.470*	45.61 Profit of 3,330 on sale
2025-02-28	SELL	-17,477	47.090*	45.59 Profit of 796,745 on sale
2025-02-26	SELL	-118	45.530*	45.58 Profit of 5,378 on sale
2025-02-25	SELL	-354	44.400*	45.60 Profit of 16,142 on sale
2025-02-18	BUY	590	42.270*	45.58
2025-02-13	BUY	118	40.300*	45.90
2025-02-12	BUY	118	40.260*	46.01
2025-02-11	BUY	354	40.110*	46.14
2025-02-06	BUY	1,062	41.540*	46.47
2025-01-27	BUY	118	40.400*	47.68
2024-12-30	BUY	590	41.890*	48.41
2024-12-06	BUY	472	44.650*	48.87
2024-12-05	BUY	118	43.860*	49.04
2024-12-04	BUY	590	45.485*	49.17
2024-11-29	BUY	590	44.840*	49.49
2024-11-27	BUY	468	44.970*	49.88
2024-11-26	BUY	117	45.870*	50.06
2024-11-21	BUY	585	44.355*	50.85
2024-11-20	BUY	351	42.930*	51.29
2024-11-18	BUY	1,404	44.270*	52.22
2024-11-12	BUY	936	51.630*	52.25
2024-11-08	BUY	585	54.500*	52.09
2024-11-07	BUY	1,755	54.500*	51.91
2024-11-06	BUY	234	53.130*	51.81
2024-10-31	BUY	117	49.930*	52.31

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of MRUS

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	123,755	15,565	295,324	41.9%
2025-09-18	97,316	4,160	228,737	42.5%
2025-09-17	144,327	1,098	242,465	59.5%
2025-09-16	109,960	2,131	222,434	49.4%
2025-09-15	149,890	0	318,679	47.0%
2025-09-12	313,455	5,537	606,036	51.7%
2025-09-11	186,041	17,755	345,081	53.9%
2025-09-10	77,299	0	149,184	51.8%
2025-09-09	109,277	12,250	231,075	47.3%
2025-09-08	110,300	0	207,990	53.0%
2025-09-05	113,743	2,003	270,192	42.1%
2025-09-04	71,390	0	194,435	36.7%
2025-09-03	118,236	1,764	269,037	43.9%
2025-09-02	104,542	485	304,738	34.3%
2025-08-29	88,408	602	208,720	42.4%
2025-08-28	205,679	1,769	570,454	36.1%
2025-08-27	43,727	0	107,171	40.8%
2025-08-26	49,221	0	280,420	17.6%
2025-08-25	51,161	0	113,717	45.0%
2025-08-22	100,156	7,575	192,111	52.1%
2025-08-21	72,411	5,956	216,042	33.5%
2025-08-20	59,660	0	265,385	22.5%
2025-08-19	94,849	0	242,816	39.1%
2025-08-18	49,307	2,689	113,536	43.4%
2025-08-15	64,984	10,335	112,733	57.6%
2025-08-14	76,844	0	278,924	27.6%
2025-08-13	178,506	1,001	423,476	42.2%
2025-08-12	86,718	1,133	254,301	34.1%
2025-08-11	84,695	390	117,680	72.0%
2025-08-08	112,422	1,666	230,834	48.7%
2025-08-07	130,196	179	222,638	58.5%
2025-08-06	255,436	0	409,279	62.4%
2025-08-05	102,319	5,000	286,822	35.7%
2025-08-04	43,196	0	67,788	63.7%
2025-08-01	111,333	0	277,022	40.2%
2025-07-31	164,449	300	435,717	37.7%
2025-07-30	114,739	0	179,110	64.1%
2025-07-29	69,987	0	152,833	45.8%
2025-07-28	117,863	0	253,637	46.5%
2025-07-25	170,530	0	303,999	56.1%
2025-07-24	254,664	4,904	482,530	52.8%
2025-07-23	145,170	0	217,503	66.7%
2025-07-22	139,563	525	302,776	46.1%
2025-07-21	287,134	1,374	573,961	50.0%
2025-07-18	269,923	0	465,096	58.0%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE